The Commission proposes to revise the EU’s pharmaceutical legislation – the largest reform in over 20 years – to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more available, accessible and affordable. It will support innovation and boost the competitiveness and attractiveness of the EU pharmaceutical […]
Read More
EU-UK relations: Commission extends arrangements for veterinary medicines to 2025
The European Commission has today adopted a notice which extends to 31 December 2025 the current arrangements for the movement of veterinary medicines from Great Britain to Cyprus, Ireland, Malta and Northern Ireland. This will ensure the continuity of supplies of veterinary medicinal products, in particular to Northern Ireland. The Commission recognises the key importance of veterinary […]
Read More
HERA signs Joint Procurement contract COVID-19 treatments
The Commission’s Health Preparedness and Response Authority (HERA) has signed a joint procurement Framework Contract for the supply of Paxlovid, a SARS-CoV-2 protease inhibitor oral treatment for patients with COVID-19 at risk of developing severe disease. The contract is signed with the pharmaceutical company Pfizer and will run for an initial period of 12 months. Thirteen […]
Read More
HERA secures up to 2 million doses of the monkeypox vaccine
The Commission’s Health Preparedness and Response Authority (HERA), has signed a Joint Procurement Framework contract with the company Bavarian Nordic, for the supply of up to 2 million doses of the monkeypox vaccine in the course of 2023 and 2024. This offers 14 participating countries the possibility to purchase doses to address their medium- and […]
Read More
Data on antimicrobial resistance (AMR): use of antibiotics in the EU decreases but more needs to be done
On the eve of European Antibiotics Awareness Day (EAAD), a pan-European survey on antimicrobial resistance shows that half of Europeans still incorrectly believe that antibiotics kill viruses. At the same time, 23 % of respondents have taken antibiotics over the past year, the lowest figure since 2009 and clearly showing that the work of Member States […]
Read More
COVID-19 vaccines: Commission and Moderna delivery schedules
The European Commission and Moderna have reached an agreement to better address Member States needs for COVID-19 vaccines for the late summer and winter period. This will ensure national authorities have access to the vaccines, including variant-adapted vaccines if authorised, at the time they need them for their own vaccination campaigns and to support their […]
Read MoreHERA signs Joint Procurement contract for Pandemic Influenza Vaccine
Today, the European Commission, via its Health Emergency Preparedness and Response Authority, signed a framework contract for the joint procurement of Adjupanrix, a pandemic influenza vaccine, with the pharmaceutical company GSK. 12 Member States and other joint procurement countries are participating in the agreement, under which they can purchase up to 85,000,000 vaccine doses if necessary, in the […]
Read More
Council adopts proposals aimed at securing the supply of medicines
Background With these proposals, the European Union intends to facilitate the implementation of the Protocol on Ireland/Northern Ireland on the ground, in line with the measures for Northern Ireland presented by the Commission on 13 October 2021. European Health Union: a stronger role for the European Medicines Agency About the proposals EU ambassadors today agreed on […]
Read More
The European Commission considers making COVID-19 vaccine compulsory
The Commission is today putting forward a common and coordinated EU approach to address effectively the challenges from the resurgence of COVID-19 in many Member States this autumn. There are rapidly rising case numbers and a renewed pressure on hospitals, which calls for urgent and determined action. The new potential threat from the Omicron variant […]
Read More